RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Endotoxemia
Accession: DOID:9005930
browse the term
Definition: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
Synonyms: exact_synonym: Endotoxemias
primary_id: MESH:D019446
G
Abcb11
ATP-binding cassette, sub-family B member 11
ISO
RGD
PMID:9828229
RGD:1598596
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:26977098
RGD:11041000
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20300455 PMID:9828229
RGD:1598596
NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
G
Abcc2
ATP-binding cassette, sub-family member 2
ISO
RGD
PMID:16572733
RGD:1598611
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcc8
ATP-binding cassette, sub-family C member 8
ISO
RGD
PMID:17285300
RGD:2301914
NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457
G
Ace
angiotensin I converting enzyme
ISO
associated with Hemorrhage;protein:decreased activity:plasma (rat)
RGD
PMID:3028670
RGD:8142370
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ache
acetylcholinesterase
ISO
RGD
PMID:17657467
RGD:5688055
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Actc1
actin, alpha, cardiac muscle 1
ISO
RGD
PMID:11680626
RGD:1598729
NCBI chr 2:113,877,763...113,883,356
Ensembl chr 2:113,877,763...113,884,029
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
protein:increased expression:plasma, spleen
RGD
PMID:23025351
RGD:9681752
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
associated with Obesity
RGD
PMID:23838384
RGD:8695926
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor2
adiponectin receptor 2
severity
ISO
associated with obesity;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Adra2a
adrenergic receptor, alpha 2a
onset
ISO
mRNA:increased expression:spleen
RGD
PMID:20302880
RGD:6480487
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Agtr1a
angiotensin II receptor, type 1a
ISO
protein:increased expression:kidney
RGD
PMID:16725227
RGD:6903849
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Agtr2
angiotensin II receptor, type 2
ISO
protein:decreased expression:kidney
RGD
PMID:16725227
RGD:6903849
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
G
Ahr
aryl-hydrocarbon receptor
severity
IMP
RGD
PMID:24930766
RGD:39939032
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Akp3
alkaline phosphatase 3, intestine, not Mn requiring
IMP
RGD
PMID:23569246
RGD:14349049
NCBI chr 1:87,052,676...87,056,450
Ensembl chr 1:87,052,695...87,055,634
G
Akt1
thymoma viral proto-oncogene 1
ISO
RGD
PMID:22824368
RGD:38676479
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Aldoa
aldolase A, fructose-bisphosphate
ISO
RGD
PMID:16930621
RGD:1599054
NCBI chr 7:126,394,406...126,399,537
Ensembl chr 7:126,394,406...126,399,923
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15328337
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Apoa1
apolipoprotein A-I
treatment
ISO
RGD
PMID:18593575 PMID:23227448
RGD:7241573 , RGD:7241868
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apob
apolipoprotein B
ISO
RGD
PMID:16719989
RGD:1599165
NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
G
Apoe
apolipoprotein E
ISO
rat model treated with human protein
RGD
PMID:9153287
RGD:6904216
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Asl
argininosuccinate lyase
ISO
RGD
PMID:10652239
RGD:1599265
NCBI chr 5:130,040,099...130,053,222
Ensembl chr 5:130,040,099...130,058,088
G
Ass1
argininosuccinate synthetase 1
ISO
RGD
PMID:10652239
RGD:1599265
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
G
Atf2
activating transcription factor 2
treatment
ISO
protein:increased expression, increased activity:small intestine mucosa
RGD
PMID:21641970 PMID:24312512
RGD:5135029 , RGD:10047418
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
G
Atp5f1a
ATP synthase F1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr18:77,861,468...77,870,569
Ensembl chr18:77,861,429...77,870,569
G
Bax
BCL2-associated X protein
ISO
mRNA:increased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bche
butyrylcholinesterase
ISO
RGD
PMID:17657467
RGD:5688055
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl2
B cell leukemia/lymphoma 2
ISO
mRNA:decreased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
C5ar1
complement component 5a receptor 1
ISO
mRNA:increased expression:lung
RGD
PMID:9272704
RGD:70679
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
Casp1
caspase 1
ISO
RGD
PMID:17384935
RGD:2315892
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Casp3
caspase 3
ISO
mRNA:increased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
IMP
RGD
PMID:19168786
RGD:5684539
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Casp9
caspase 9
treatment
ISO
RGD
PMID:23214195
RGD:10400903
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cbs
cystathionine beta-synthase
severity
IMP IEP ISO
Protein:increased expression:spleen, lung (mouse) mRNA:increased expression:liver (rat)
RGD
PMID:27748832 PMID:27748832 PMID:24702258 PMID:16100527
RGD:40903019 , RGD:40903019 , RGD:40903035 , RGD:40903049
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:plasma
RGD
PMID:19060786
RGD:2307004
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:plasma
RGD
PMID:16215387
RGD:2307171
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccr1
C-C motif chemokine receptor 1
IMP
RGD
PMID:17016504
RGD:5688178
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
G
Cd14
CD14 antigen
ISO
protein:increased expression:liver, endothelial cell of sinusoid
RGD
PMID:12046090
RGD:724637
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd40
CD40 antigen
IDA
protein:decreased nitrosylation:macrophage
RGD
PMID:20473113
RGD:5490974
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cebpb
CCAAT/enhancer binding protein beta
treatment
ISO IDA
RGD
PMID:15192048 PMID:14659593
RGD:1625687 , RGD:40903034
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cps1
carbamoyl-phosphate synthetase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418
G
Cs
citrate synthase
ISO
protein:increased expression:gastrocnemius
RGD
PMID:25674200
RGD:329337350
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:9514298
RGD:11039535
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:atrium endocardium
RGD
PMID:19282612
RGD:4891965
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl5
C-X-C motif chemokine ligand 5
IEP
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Edn1
endothelin 1
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:11206318
RGD:8662297
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Ep300
E1A binding protein p300
ISO
associated with Kidney Reperfusion Injury; protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Ephx2
epoxide hydrolase 2, cytoplasmic
IMP
RGD
PMID:19154430
RGD:5688360
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:23214195
RGD:10400903
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
F12
coagulation factor XII (Hageman factor)
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
G
F2
coagulation factor II
treatment severity
ISO
associated with liver cirrhosis;protein:increased expression:blood plasma (human) associated with liver cirrhosis;protein:increased expression:plasma (human)
RGD
PMID:21396682 PMID:10604885 PMID:7615203 PMID:10887118 PMID:9863491 PMID:25396762 PMID:22227956 PMID:20519137 More...
RGD:5147765 , RGD:40818436 , RGD:14974253 , RGD:40818427 , RGD:14401592 , RGD:10449434 , RGD:6893482 , RGD:5147779
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F3
coagulation factor III, tissue factor
treatment
ISO IMP
associated with Protein C Deficiency
RGD
PMID:21396682 PMID:20858853 PMID:8956768
RGD:5147765 , RGD:11341685 , RGD:11340208
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
F5
coagulation factor V
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
G
F7
coagulation factor VII
treatment
ISO IMP
RGD
PMID:11092686 PMID:16378835
RGD:7394782 , RGD:11041650
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
F8
coagulation factor VIII
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr X:74,213,950...74,426,342
Ensembl chr X:74,216,321...74,426,221
G
Fas
Fas cell surface death receptor
ISO
mRNA, protein:increased expression:spleen (rat)
RGD
PMID:20428798
RGD:8662930
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fga
fibrinogen alpha chain
treatment
ISO
RGD
PMID:19295478
RGD:11040925
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Foxp3
forkhead box P3
ISO
protein:increased expression:intestinal mucosa
RGD
PMID:19998507
RGD:38455980
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
mRNA:increased expression:lung associated with liver cirrhosis
RGD
PMID:9388472 PMID:16845913 PMID:14647062
RGD:329961576 , RGD:401793756 , RGD:401700399
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Gfer
growth factor, augmenter of liver regeneration
ISO
RGD
PMID:23073658
RGD:9685733
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
G
Ghr
growth hormone receptor
ISO
mRNA:decreased expression:liver
RGD
PMID:12654216 PMID:12217886
RGD:2307380 , RGD:625688
NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
RGD
PMID:25514429
RGD:401717525
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:25469663
RGD:10401928
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:heart, serum
RGD
PMID:18503231
RGD:10402065
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmox1
heme oxygenase 1
treatment
ISO
RGD
PMID:21396999
RGD:10755715
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hsf1
heat shock factor 1
treatment
ISO
RGD
PMID:25571843
RGD:10402404
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
G
Hspa9
heat shock protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
G
Hspd1
heat shock protein 1 (chaperonin)
ISO
mRNA, protein:increased expression:medulla oblongata CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16741687 PMID:16675490
RGD:1624232
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung (rat)
RGD
PMID:19776691
RGD:4145502
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ido1
indoleamine 2,3-dioxygenase 1
IMP
RGD
PMID:24930766 PMID:28077574
RGD:39939032 , RGD:39939117
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ido2
indoleamine 2,3-dioxygenase 2
IMP
RGD
PMID:24930766
RGD:39939032
NCBI chr 8:25,021,908...25,066,430
Ensembl chr 8:25,021,908...25,066,349
G
Ifng
interferon gamma
ISO
protein:increased expression:serum:
RGD
PMID:9195172
RGD:10755747
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf1
insulin-like growth factor 1
ISO
mRNA, protein:decreased expression:liver, serum
RGD
PMID:18492809 PMID:12217886
RGD:10402757 , RGD:625688
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr17:25,096,818...25,100,985
Ensembl chr17:25,084,971...25,100,984
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
mRNA, protein:decreased expression:liver, serum
RGD
PMID:18492809
RGD:10402757
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Igfbp5
insulin-like growth factor binding protein 5
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043
G
Il10
interleukin 10
treatment
IEP
RGD
PMID:28664613 PMID:27943364
RGD:14975137 , RGD:14975170
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
treatment
ISO
RGD
PMID:10674721
RGD:8549626
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il1a
interleukin 1 alpha
IEP ISO
protein:increased expression:plasma
RGD
PMID:9636192 PMID:22426124
RGD:6907109 , RGD:7794786
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:plasma
RGD
PMID:17201737
RGD:1626625
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
mRNA:increased expression:lung, spleen, liver (rat)
RGD
PMID:1385928 PMID:8855299
RGD:8551846 , RGD:11522760
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6
interleukin 6
ISO
associated with Diabetes Mellitus, Experimental; Protein:increased expression:extracellular space (rat) protein:increased expression:serum (rat)
RGD
PMID:19449282 PMID:21396682 PMID:22227956
RGD:2307179 , RGD:5147765 , RGD:6893482
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak3
interleukin-1 receptor-associated kinase 3
ISO
mRNA, protein:increased expression:blood (human)
RGD
PMID:17982103
RGD:36049802
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Irs1
insulin receptor substrate 1
IDA
protein:increased tyrosine nitration, decreased tyrosine phosphorylation:skeletal muscle
RGD
PMID:21206533
RGD:6483008
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
G
Itga2b
integrin alpha 2b
ISO
RGD
PMID:15280099
RGD:2316360
NCBI chr11:102,344,134...102,360,570
Ensembl chr11:102,344,123...102,360,948
G
Itgb3
integrin beta 3
ISO
RGD
PMID:15280099
RGD:2316360
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Keap1
kelch-like ECH-associated protein 1
IMP
RGD
PMID:22609006
RGD:6892951
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Lbp
lipopolysaccharide binding protein
treatment
ISO IMP
mRNA:increased expression:hepatocyte
RGD
PMID:8418776 PMID:8593028 PMID:16307218
RGD:9685191 , RGD:9685196 , RGD:9685193
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Lcn2
lipocalin 2
IEP
mRNA:increased expression:brain,liver
RGD
PMID:21943033
RGD:126779582
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Map2
microtubule-associated protein 2
IEP
mRNA, protein:decreased expression:neuron
RGD
PMID:21421895
RGD:6483086
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
G
Mapk14
mitogen-activated protein kinase 14
treatment
ISO
protein:increased activity:small intestine mucosa
RGD
PMID:21641970 PMID:24312512
RGD:5135029 , RGD:10047418
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk8
mitogen-activated protein kinase 8
ISO
protein:increased phophorylation:hippocampus (rat)
RGD
PMID:12207162
RGD:150340687
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mc4r
melanocortin 4 receptor
ISO
mRNA:increased expression:paraventricular nucleus (rat)
RGD
PMID:21343543
RGD:6484214
NCBI chr18:66,990,776...66,993,558
Ensembl chr18:66,990,775...66,993,577
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
protein:increased expression:plasma
RGD
PMID:16601957
RGD:1641983
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir146
microRNA 146
treatment
IEP
miRNA:increased expression:spleen (mouse)
RGD
PMID:30867482
RGD:34888227
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir155
microRNA 155
treatment
IEP
associated with familial hyperlipidemia
RGD
PMID:28970282 PMID:28264607 PMID:29079998 PMID:29979224
RGD:21079445 , RGD:24922204 , RGD:21081539 , RGD:21081538
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mme
membrane metallo endopeptidase
severity
ISO
RGD
PMID:11078421
RGD:13801040
NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:17083784
RGD:2290426
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mt2
metallothionein 2
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:22100509
RGD:6483852
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mt3
metallothionein 3
ISO
RGD
PMID:12135776
RGD:10412330
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
G
Muc2
mucin 2
ISO
RGD
PMID:19099858
RGD:7349370
NCBI chr 7:141,276,583...141,308,428
Ensembl chr 7:141,276,583...141,308,430
G
Myh6
myosin, heavy polypeptide 6, cardiac muscle, alpha
ISO
RGD
PMID:7874842
RGD:12792976
NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384
G
Myh7
myosin, heavy polypeptide 7, cardiac muscle, beta
ISO
RGD
PMID:7874842
RGD:12792976
NCBI chr14:55,208,141...55,232,083
Ensembl chr14:55,208,141...55,232,083
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
ISO
RGD
PMID:26646455
RGD:42722616
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
exacerbates treatment
IMP IEP
RGD
PMID:19098124 PMID:10229101
RGD:126908017 , RGD:126928139
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nos2
nitric oxide synthase 2, inducible
ISO
mRNA, protein:increased expression:intestine CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12620498 PMID:16787348 PMID:20519137
RGD:4891470 , RGD:5147779
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
ISO
protein:increased expression:aorta (rat)
RGD
PMID:10462376
RGD:7794732
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Npy
neuropeptide Y
treatment
ISO
RGD
PMID:15342191
RGD:1580787
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
RGD
PMID:15640646
RGD:4892561
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Otc
ornithine transcarbamylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
ISO
RGD
PMID:19268478 PMID:12217886
RGD:10427879 , RGD:625688
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
ISO
mRNA,protein:decreased expression,decreased activity:liver:
RGD
PMID:19268478
RGD:10427879
NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699
G
Pcsk1
proprotein convertase subtilisin/kexin type 1
ISO
RGD
PMID:16337011
RGD:6483567
NCBI chr13:75,237,407...75,282,980
Ensembl chr13:75,237,945...75,282,980
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
ISO
RGD
PMID:16337011
RGD:6483567
NCBI chr 2:143,388,053...143,658,204
Ensembl chr 2:143,388,076...143,658,205
G
Pecam1
platelet/endothelial cell adhesion molecule 1
IMP
RGD
PMID:22119535
RGD:6771174
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pf4
platelet factor 4
treatment
ISO
RGD
PMID:20601223
RGD:329901905
NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
G
Pgf
placental growth factor
IEP
protein:increased expression:multiple
RGD
PMID:16702604
RGD:6483601
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pla2g7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
ISO
protein:increased expression: :
RGD
PMID:10748027
RGD:7248791
NCBI chr17:43,879,009...43,923,093
Ensembl chr17:43,878,989...43,923,092
G
Plat
plasminogen activator, tissue
treatment
ISO
RGD
PMID:9091588
RGD:11541073
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:small intestine mucosa
RGD
PMID:21641970
RGD:5135029
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Prkaa1
protein kinase, AMP-activated, alpha 1 catalytic subunit
IEP
mRNA:decreased expression:epididymal fat pad
RGD
PMID:20421294
RGD:6484543
NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
G
Prkn
parkin RBR E3 ubiquitin protein ligase
IEP
protein:increased expression:liver, mitochondrion (mouse)
RGD
PMID:28615325
RGD:13432559
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
Proc
protein C
treatment
ISO
RGD
PMID:18205901 PMID:23170801
RGD:11100030 , RGD:11100034
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Ptafr
platelet-activating factor receptor
treatment
ISO
RGD
PMID:2178565
RGD:10041063
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
ISO
protein:increased expression:paraventricular hypothalamic nucleus parvicellular division (rat)
RGD
PMID:11058222
RGD:10043329
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Ptgis
prostaglandin I2 (prostacyclin) synthase
treatment
ISO
RGD
PMID:11076704
RGD:401960076
NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21641970
RGD:5135029
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ren1
renin 1 structural
IEP ISO
protein:increased activity:blood plasma (mouse) protein:increased activity:blood plasma (rat)
RGD
PMID:30027346 PMID:16512638
RGD:125097481 , RGD:125097499
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
treatment
ISO
RGD
PMID:16457847 PMID:21396682 PMID:20519137 PMID:15995859
RGD:1599326 , RGD:5147765 , RGD:5147779 , RGD:1599332
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
RGD
PMID:21396682 PMID:25396762
RGD:5147765 , RGD:10449434
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12386642
RGD:36174005
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
treatment
ISO
RGD
PMID:18652771
RGD:8661643
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Slc18a3
solute carrier family 18 (vesicular monoamine), member 3
ISO
protein:decreased expression:parietal cortex
RGD
PMID:17306796
RGD:5686693
NCBI chr14:32,184,394...32,186,807
Ensembl chr14:32,184,395...32,186,807
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
treatment
ISO
RGD
PMID:18313662
RGD:7243881
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
treatment
ISO
RGD
PMID:18313662
RGD:7243881
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc38a3
solute carrier family 38, member 3
ISO
RGD
PMID:20036385
RGD:9999227
NCBI chr 9:107,528,353...107,546,167
Ensembl chr 9:107,527,833...107,546,729
G
Slc38a5
solute carrier family 38, member 5
ISO
RGD
PMID:20036385
RGD:9999227
NCBI chr X:8,137,620...8,146,418
Ensembl chr X:8,137,372...8,146,418
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
ISO
RGD
PMID:26337286
RGD:151361133
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Slpi
secretory leukocyte peptidase inhibitor
ISO
RGD
PMID:25466948
RGD:9999425
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Socs1
suppressor of cytokine signaling 1
IEP
mRNA:increased expression:liver, skeletal muscle
RGD
PMID:15169905
RGD:2298923
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Socs3
suppressor of cytokine signaling 3
IEP ISO
mRNA:increased expression:liver, skeletal muscle
RGD
PMID:15169905 PMID:12217886
RGD:2298923 , RGD:625688
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sparc
secreted acidic cysteine rich glycoprotein
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:10703670
RGD:2300026
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Stat5b
signal transducer and activator of transcription 5B
ISO
protein:decreased tyrosine phosphorylation:liver
RGD
PMID:17327369
RGD:1601383
NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550
G
Tbxa2r
thromboxane A2 receptor
ISO
RGD
PMID:15647606 PMID:2580129
RGD:1601450 , RGD:11059531
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
Tbxas1
thromboxane A synthase 1, platelet
ISO
RGD
PMID:15647606
RGD:1601450
NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
G
Tdo2
tryptophan 2,3-dioxygenase
severity
IMP
RGD
PMID:24930766
RGD:39939032
NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:17537762
RGD:11062086
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Thbd
thrombomodulin
ISO IEP
mRNA:decreased expression:endothelial cell
RGD
PMID:12611420 PMID:20348393 PMID:19487933
RGD:1601652 , RGD:5685037 , RGD:5684988
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Timp3
tissue inhibitor of metalloproteinase 3
ISO
RGD
PMID:17083784
RGD:2290426
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
G
Tlr2
toll-like receptor 2
treatment
ISO
associated with liver cirrhosis
RGD
PMID:22172266 PMID:12610323
RGD:7241094 , RGD:597538466
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
treatment disease_progression
ISO IEP IMP
mRNA:increased expression:liver:
RGD
PMID:22172266 PMID:23977376 PMID:23977376
RGD:7241094 , RGD:14697731 , RGD:14697731
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
treatment
ISO IEP
protein:increased expression:plasma protein:increased expression:plasma (rat) associated with liver cirrhosis XCO:0000822 JTE-607
RGD
PMID:17324147 PMID:20519137 PMID:21396682 PMID:12813371 PMID:8283134 PMID:18078960 PMID:15242491 PMID:10493164 More...
RGD:4891465 , RGD:5147779 , RGD:5147765 , RGD:14995427 , RGD:14995443 , RGD:15023464 , RGD:38501090 , RGD:40903016
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trem1
triggering receptor expressed on myeloid cells 1
treatment
IEP ISO
RGD
PMID:21507332 PMID:15585833
RGD:126925982 , RGD:126928122
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Vcam1
vascular cell adhesion molecule 1
ISO
mRNA:increased expression:brain:
RGD
PMID:20061033
RGD:7240511
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vwf
Von Willebrand factor
ISO
protein:increased expression:endothelial cell:
RGD
PMID:2650559
RGD:11079230
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:8602831
RGD:329961578
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
treatment
ISO
RGD
PMID:19318092
RGD:401901206
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all